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PJ-Point Elevation in Survivors of Primary
Ventricular Fibrillation and Matched Control Subjects
Incidence and Clinical Significance
Raphael Rosso, MD,* Evgeni Kogan, MD,* Bernard Belhassen, MD,* Uri Rozovski, MD,*
Melvin M. Scheinman, MD,§ David Zeltser, MD,* Amir Halkin, MD,* Arie Steinvil, MD,*
Karin Heller, MD,* Michael Glikson, MD,† Amos Katz, MD,‡ Sami Viskin, MD*
Tel Aviv and Beer-Sheva, Israel; and San Francisco, California
Objectives The purpose of this study was to determine whether J-point elevation is a marker of arrhythmic risk.
Background J-point elevation has been considered an innocent finding among healthy young individuals (the “early repolar-
ization” pattern). However, this electrocardiogram (ECG) finding is increasingly being associated with idiopathic
ventricular fibrillation (VF).
Methods In a case-control study, the ECG of 45 patients with idiopathic VF were compared with those of 124 age- and
gender-matched control subjects and with those of 121 young athletes. We measured the height of J-point and
ST-segment elevation and counted the presence of slurring in the terminal portion of the R-wave.
Results J-point elevation was more common among patients with idiopathic VF than among matched control subjects
(42% vs. 13%, p  0.001). This was true for J-point elevation in the inferior leads (27% vs. 8%, p  0.006) and
for J-point elevation in leads I to aVL (13% vs. 1%, p  0.009). J-point elevation in V4 to V6 occurred with equal
frequency among patients and matched control subjects (6.7% vs. 7.3%, p  0.86). Male subjects had J-point
elevation more often than female subjects and young athletes had J-point elevation more often than healthy
adults but less often than patients with idiopathic VF. The presence of ST-segment elevation or QRS slurring did
not add diagnostic value to the presence of J-point elevation.
Conclusions J-point elevation is found more frequently among patients with idiopathic VF than among healthy control sub-
jects. The frequency of J-point elevation among young athletes is intermediate (higher than among healthy
adults but lower than among patients with idiopathic VF). (J Am Coll Cardiol 2008;52:1231–8) © 2008 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.07.010c
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nince the description of the Brugada syndrome (1), J-point
nd ST-segment elevation in the right precordial leads is
iewed as a marker of increased arrhythmic risk in patients
ith no organic heart disease (2,3). In contrast, J-point and
T-segment elevation in the lateral leads is considered an
nnocent finding because it is often observed in healthy
oung individuals (the so called “early repolarization” vari-
nt) (4).
Recently, several case reports called our attention to the
ssociation of idiopathic ventricular fibrillation (VF) with
-point elevation (with or without ST-segment elevation) in
he inferior (5–12) or lateral leads (13–15). Therefore, we
rom the *Tel Aviv Medical Center and †Sheba Medical Center, Sackler School of
edicine, Tel Aviv University, Tel Aviv, Israel; ‡Soroka Medical Center and Ben
urion University, Beer-Sheva, Israel; and the §University of California San
rancisco, San Francisco, California.d
Manuscript received April 21, 2008; revised manuscript received July 7, 2008,
ccepted July 14, 2008.onducted the present study to determine whether J-point
levation with or without ST-segment elevation—in leads
ther than V1 to V3—is an innocent finding or a marker
ssociated with a history of VF in patients without heart
isease. After completion of this study, a similar study was
ublished by Haissaguerre et al. (16).
ethods
atient group. The “VF Group” consisted of 45 patients
ages 14 to 69 years, mean age 38  15 years; 71% male).
his group consisted of 43 patients with a clinical diagnosis
f idiopathic VF on the basis of rigorous criteria (17) and 2
atients eventually diagnosed with Brugada syndrome (see
he following text). These patients have been reported in
revious publications describing the clinical characteristics
f idiopathic VF (18), the mode of onset of their sponta-
eous arrhythmias (19), their high VF-inducibility rate
uring electrophysiologic studies (20,21), and their response
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J-Point Elevation in Idiopathic VF October 7, 2008:1231–8to quinidine therapy (20,21). Es-
sentially, idiopathic VF was di-
agnosed by exclusion in cardiac
arrest survivors when a complete
work-up for alternative etiologies
was negative (17) and was diag-
nosed with confidence in patients
with syncope or cardiac arrest
hen spontaneous polymorphic ventricular tachycardia/VF,
ith all of the unique characteristics of idiopathic VF (19),
as recorded. Familial relations do not exist between the VF
atients; none of them has additional family members with
alignant ventricular arrhythmias, and none is of South
ast Asian origin. The main objective of this study was to
etermine the diagnostic value of J-point elevation in leads
ther than V1 to V3 in patients with no organic heart
isease. Accordingly, we included in the VF group 2
atients ultimately diagnosed with Brugada syndrome.
hese patients (both male, ages 28 and 42 years) have
trictly normal QRS and ST segments in V1 to V3 in the
aseline electrocardiogram (ECG) (Fig. 1), and the diag-
osis of Brugada syndrome became apparent only after
nterventions (i.e., they developed type-I ST-segment ele-
ation in V1 to V3 [2] after placement of the V1 to V3
lectrodes at a higher intercostal space [22] or a flecainide
hallenge test [2]). In contrast, patients with Brugada
yndrome with any pathology in V1 to V3 on their baseline
CG, were excluded.
ontrol groups. Two patient cohorts served as control
ubjects: a “matched control” and a “young-athletes” group.
he matched-control group consisted of 3 control subjects
Abbreviations
and Acronyms
CI  confidence interval
ECG  electrocardiogram
OR  odds ratio
VF  ventricular fibrillation
Figure 1 Electrocardiogram of a 45-Year-Old Man in the Ventric
This patient was eventually diagnosed as Brugada syndrome. Note that leads V1 t
in leads II, III, and aVF is obvious. Note also the ventricular extrasystoles with shoatched for age and gender for each VF patient. Control
ubjects ages 24 to 70 years were recruited from among
,500 adults participating in the Tel Aviv Medical Screen-
ng program in 2007. Screening included history, exami-
ation, ECG, and exercise testing of all patients and
dditional tests as necessary. Control subjects qualified
or inclusion if: 1) the screening report mentioned “no
istory of syncope” and “no history of heart disease”;
) the ECG was reported as normal (J-point elevation
ould not be considered abnormal in this screening
rogram); and 3) screening did not reveal heart disease.
he first 3 control subjects with these characteristics, who
atched each idiopathic VF patient by age (within 2
ears) and gender, were included. For younger control
ubjects we studied healthy medical personnel or their
ffspring (again, 3 control subjects/patient). Subsequently,
1 control subjects were excluded for the following reasons:
ncidental finding of left bundle branch block (1 medical
ersonnel), 1 type-II Brugada tracing (reported as normal
CG in the screening), and ECG with noise in 1 lead or
rong age (9 patients). Thus, the matched-control con-
isted of 124 control subjects matched for age and gender to
he VF patient (2 or 3 control subjects for each patient). The
Young-Athletes” control group was studied to test the
ypothesis that that J-point elevation is more prevalent
mong young individuals (23) with increased vagal tone
24). This group consisted of 132 athletes (3 athletes for
ach VF patient) randomly selected from a pre-participation
edical screening program. These were 17- to 19-year-old
oncompetitive athletes with different levels of training con-
isting mainly of endurance running (50% of them were male).
Fibrillation Group
o not show any ST-segment elevation. In contrast, the J-point elevation
pling interval. The very short coupling interval is best appreciated in lead V .ular
o V3 d
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October 7, 2008:1231–8 J-Point Elevation in Idiopathic VFleven of the ECG tracings were disqualified due to back-
round noise or missing 1 lead, so that the “young control
roup” ultimately consisted of 121 athletes.
easurements. To blind ECG interpreters to patient
rouping, all tracings were scanned and coded. Segments
howing extra-systoles were not used. However, some of the
CG traces of idiopathic VF patients were old, and com-
lete blinding was impossible for all traces. The scanned
CGs were reviewed in random order by 3 investigators.
rading was by consensus. “J-point elevation” or “J waves”
ere defined as positive “hump-like” deflections immedi-
tely after a positive QRS complex at the onset of the
T-segment. Because J-point elevation might be hidden in
he QRS complex (25), we also noted the presence of
slurring” at the terminal part of the QRS complex. The
ransition from the QRS complex to the ST-segment was
efined as “slurred” when the R-wave gradually became the
T-segment with upright concavity and as “J-point eleva-
ion” when a sharp and well-defined hump was noted
mmediately after the R-wave (23). The height of the
-point and/or ST-segment elevation from the baseline was
easured with an electronic caliper after the scanned ECGs
ere enlarged 4 times. The ST-segment elevation was
easured at its most horizontal section.
tatistics. Continuous variables are displayed as mean 
D, and categorical variables are presented as number and
ercent in each group. Comparison of continuous variables
etween patients and matched control subjects was done
ith blocked analysis of variance, where the blocks are
efined as each case with all its matched control subjects,
nder the general linear model procedure. Comparison of all
ichotomous variables between patients and matched con-
rol subjects was done with the conditional logistic regres-
ion analysis. Results are displayed as the odds ratio (OR)
lus 95% confidence intervals (CIs). All aforementioned
nalyses were considered significant at p  0.05 (2-tailed).
he SPSS statistical package (SSPS Inc., Chicago, Illinois)
as used to perform all statistical evaluations.
Calculating the positive predictive value of J-point eleva-
ion for diagnosing idiopathic VF would lead to gross
verestimation, because our study population consisted of 1
F patient for every 2 to 3 control subjects, whereas in the
eal world idiopathic VF is far more infrequent. To translate
he significance of our findings into clinical practice, we
sed the Bayes’ theorem (26) to determine the conditional
robability of having idiopathic VF, when J-point elevation
s detected, with the formula:
PJ (IVF )
P (IVF ) · PIVF ( J )
P (IVF) · PIVF  J   P (notIVF ) · PnotIVF ( J )
here PJ(IVF) is the probability of having idiopathic VF,
hen J waves are present. The parameters entered into the
ormula, PIVF(J) and PnotIF(J) (the probability of having a
-point elevation for an individual with idiopathic VF and
or an individual with no IVF, respectively), were derived prom the results of the present study; P(IVF) (the incidence
f idiopathic VF in the population) was entered as 3.4/
00,000. This figure was based on epidemiological data
howing that the risk of cardiac arrest for the population
ges 35 to 45 years is 34 of 100,000 (27), whereas only 10%
f cardiac arrest events in this age group are due to
diopathic VF (18). Finally, P(not IVF), which is the
ncidence of individuals without idiopathic VF was approx-
mated to 1.
esults
-point elevation. J-point elevation was more commonly
een among patients with idiopathic VF than among
atched-control subjects (42% vs. 13%, p  0.001). This
as particularly true for J-point elevation in the inferior
eads (27% vs. 8%, p  0.006) and was also true for J-point
levation in leads I to aVL (13% vs. 1%, p  0.009). In
ontrast, J-point elevation in V4 to V6 occurred with equal
requency among patients and matched-control subjects
6.7% vs. 7.3%, p  0.86) (Table 1, Figs. 1 and 2).
J-point elevation 0.05 mV (or 0.1 mV) was also more
requent among idiopathic VF patients (Table 1). When
-point elevation was present, it tended to be taller among
atients with idiopathic VF than among control subjects,
ut the difference did not reach statistical significance (0.14
s. 0.09 mV, p  0.099). Moreover, we could not identify
cut-off value of J-point elevation (height) that would
eliably distinguish VF patients from control subjects. Ex-
luding the 2 patients ultimately diagnosed with Brugada
yndrome from this analysis did not change the results (data
ot shown).
Patients and control subjects had similar R-R, PR, QT,
nd QTc intervals (data not shown). The R waves in leads
5 to V6 were slightly taller in the VF group (1.06 mV vs.
.86 mV, p  0.006). However, the R waves in those leads
here J-point elevation was more prevalent in the VF group
ere not taller in the VF group (0.85 mV vs. 0.89 mV and
.62 mV vs. 0.76 mV [p  NS] for the VF and matched-
ontrol groups in the inferior and high-lateral leads, respec-
ively). No correlation between R-wave amplitude and
-point elevation was found.
RS slurring. Slurring of the descending limb of the R
ave was commonly observed among patients and control
ubjects (31% vs. 24%, p  0.4). The presence of
slurring” was not useful for identifying patients with
diopathic VF regardless of the lead where it was ob-
erved (Table 2). Moreover, the presence of “QRS
lurring and J-point elevation” or the presence of “QRS
lurring or J-point elevation” did not add diagnostic value
o the presence of J-point elevation alone (Table 2, Fig. 2).
T-segment elevation. The ST-segment elevation was
ommonly observed among VF patients and control subjects
33% vs. 24%, p  0.35). The presence of ST-segment
levation was not useful for identifying patients with idio-
athic VF regardless of its magnitude or the leads where it
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J-Point Elevation in Idiopathic VF October 7, 2008:1231–8as observed (Table 3). Also, the combination of “ST-
egment elevation and J-point elevation” or the presence of
ST-segment elevation or J-point elevation” did not add
iagnostic value to the presence of J-point elevation alone
data not shown).
nfluence of gender on the incidence of J-point eleva-
ion. The influence of gender on the incidence of J waves is
est appreciated from Figure 3. Within each of the 3 patient
Incidence of J-Point Elevation Among 45 PatienVF and 124 Healthy Control Subjects Matched f
Table 1 Incidence of J-Point Elevation AmonVF and 124 Healthy Control Subjec
Idiopathic VF Co
n % n
Any lead
Any J-point elevation 19 42.2% 16
J-point 1.0 mm 14 31.1% 11
Inferior leads
Any J-point elevation 12 26.7% 10
J-point 1.0 mm 8 17.8% 8
Leads I and aVL
Any J-point elevation 6 13.3% 1
J-point 1.0 mm 5 11.1% 0
Leads V4 to V6
Any J-point elevation 3 6.7% 9
J-point 1.0 mm 3 6.7% 6
All electrocardiograms were recorded at standard gain (10 mm  1 m
CI  confidence interval; OR  odds ratio; VF  ventricular fibrillati
CBA
C1B1A
I
II
III
aVR
aVL
aVF
II
aVF
II
III
aVF
Figure 2 J-Point Elevation and R-Wave Slurring
A and B show the electrocardiograms (leads I to aVF) of 2 male subjects with idio
athlete. The lower panel shows enlargements of the respective electrocardiograms
(arrowhead). C1 demonstrates J-point elevation (arrows).roups, male subjects had J waves more often than female
ubjects. This difference remained significant even after
orrecting for gender-related differences in heart rate (not
hown) and were particularly strong when only large J waves
0.1 mV) were counted.
omparison with young athletes. Figure 4 shows 2 im-
ortant findings: 1) the frequency of J waves among young
thletes was intermediate between that observed among
th Idiopathice and Gender
Patients With Idiopathic
tched for Age and Gender
Subjects
% p Value* OR 95% CI
13.0% 0.001 3.2 1.7–6.3
8.9% 0.002 3.4 1.5–7.5
8.1% 0.006 3.2 1.4–7.5
6.5% 0.052 2.6 1.0–7.1
0.8% 0.009 16.9 2.0–140.3
0
7.3% 0.860 0.9 0.2–3.3
4.9% 0.686 1.3 0.3–5.3
value calculated with conditional logistic regression.
I
II
III
aVR
aVL
aVF
V1
V2
V3
V4
V5
V6
V4 V5 V6III
ventricular fibrillation, whereas C shows the electrocardiogram of a healthy male
emonstrates J-point elevation (arrows). B1 demonstrates slurring of the QRSts Wior Ag
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October 7, 2008:1231–8 J-Point Elevation in Idiopathic VFealthy adults and that observed in the VF group; and 2) the
istribution of J-point elevation also differed between pa-
ient groups: when healthy control subjects had J-point eleva-
ion, this occurred in leads V4 to V6 and/or in the inferior leads.
n contrast, idiopathic VF patients had J-point elevation
ainly in the inferior leads, less commonly in I to aVL and
east commonly in leads V4 to V6.
iagnostic power of J-point elevation. As mentioned
reviously (see “Statistics”), the estimated risk for idiopathic
F in the general population, ages 35 to 45 years, is roughly
.4 of 100,000 individuals. On the basis of the results of our
tudy, the probability of having J-point elevation is 0.42 for
diopathic VF patients and 0.13 for control subjects. Ac-
ording to the Bayes’ formula of conditional probabilities,
Incidence of QRS “Slurring” Among 45 PatientsVF and 124 Healthy Control Subjects Matched f
Table 2 Incidence of QRS “Slurring” AmongVF and 124 Healthy Control Subjec
Idiopathic VF
n %
Any lead
Slurred QRS 14 31.1%
Inferior leads
Slurred QRS 10 22.2%
Leads I and aVL
Slurred QRS 3 6.7%
Leads V4 to V6
Slurred QRS 2 4.4%
Any lead
Slurred QRS or J-wave 26 57.8%
Inferior leads
Slurred QRS or J-wave 17 37.8%
Leads I and aVL
Slurred QRS or J-wave 8 17.8%
Leads V4 to V6
Slurred QRS or J-wave 5 11.1%
*p value calculated with conditional logistic regression.
Abbreviations as in Table 1.
Incidence of ST-Segment Elevation Among 45 PVF and 124 Healthy Control Subjects Matched f
Table 3 Incidence of ST-Segment ElevationVF and 124 Healthy Control Subjec
Idiopathic VF
n %
Any lead
Any ST-segment elevation 15 33.3%
ST-segment elevation 1.0 mm 6 13.3%
Inferior leads
Any ST-segment elevation 6 13.3%
ST-segment elevation 1.0mm 3 6.7%
Leads I and aVL
Any ST-segment elevation 5 11.1%
ST-segment elevation 1.0 mm 1 2.2%
Leads V4 to V6
Any ST-segment elevation 8 17.8%
ST-segment elevation 1.0 mm 4 8.9%Electrocardiograms were recorded at standard gain (10 mm  1 mV). *p val
Abbreviations as in Table 1.nding a J-wave in the ECG of an individual in the 35 to
5 years age range increases the chances of having idiopathic
F from 3.4 of 100,000 individuals to only 11 of 100,000.
iscussion
-point elevation is considered an innocent finding among
ealthy young individuals (4). However, this finding is
ncreasingly being associated with idiopathic VF (5–16).
e conducted this study to define whether the presence of
-point elevation is a marker of arrhythmic risk. The ECGs
f 45 patients with idiopathic VF were compared with those
f 124 healthy control subjects matched for age and gender.
his study design was selected to avoid the bias of age and
Idiopathice and Gender
atients With Idiopathic
tched for Age and Gender
ol Subjects
% p Value* OR 95% CI
23.6% 0.441 1.3 0.7–2.4
17.1% 0.539 1.3 0.6–2.7
5.7% 0.812 1.2 0.3–4.6
4.9% 0.832 0.8 0.2–4.2
32.5% 0.029 1.7 1.1–2.8
23.6% 0.144 1.6 0.9–2.8
5.7% 0.026 3.2 1.2–8.8
12.2% 0.786 0.9 0.3–2.4
ts With Idiopathice and Gender
g 45 Patients With Idiopathic
tched for Age and Gender
Control
Subjects
n % p Value* OR 95% CI
0 24.4% 0.353 1.3 0.7–2.5
9 7.3% 0.274 1.8 0.6–5.0
1 17.1% 0.540 0.8 0.3–1.9
6 4.9% 0.694 1.3 0.3–5.3
4 3.3% 0.071 3.4 0.9–12.5
1 0.8% 0.515 2.5 0.2–40.4
4 11.4% 0.316 1.6 0.7–3.7
4 3.3% 0.154 2.7 0.7–11.0Withor Ag
45 P
ts Ma
Contr
n
29
21
7
6
40
29
7
15atienor Ag
Amon
ts Ma
3
2
1ue calculated with conditional logistic regression.
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J-Point Elevation in Idiopathic VF October 7, 2008:1231–8ender, because benign J-point elevation is found predom-
nantly in young male subjects, whereas patients with
diopathic VF are older (mean age 38 years) and only 2 of
are male. We included a second control group of young
on-competitive athletes who are expected to have a high
ncidence of benign J-point elevation (4).
requency of J-point elevation. We observed J-point
levation in 42% of VF patients and 13% of matched
ontrol subjects. When only J-point elevation 0.1 mV
Idiopathic VF
63%
31%
15%
Young athletes
54%
61%
Adult controls
62%
56%
40%
20%
10%
Leads 
V4-V6
Inferior 
leads
Leads 
I-aVL
Figure 4 Distribution of J Waves Among Patients With Idiopathic
VF, Matched Control Subjects, and Healthy Athletes
The bars show the percentage of individuals with J-point elevation in each of
the 3 patient groups. The y axis denotes the percentage of patients with
J-point elevation in any lead. The partition of each bar demonstrates the distri-
bution of J-point elevation in the different leads (the numbers within the bars
exceed 100%, because some patients had J-point elevation in more than 1
0
10
20
30
40
50
60
Any J-point elevatio
Control 
Adults
Young 
Athletes
Idiopat
VF
**
Males
Females
Figure 3 Influence of Gender on the Incidence of J-Point Elevat
*p  0.05; **p  0.005 by Fisher exact test. VF  ventricular fibrillation.cas counted, the numbers were 31% vs. 9% (p  0.002).
hese results are remarkably similar to those recently
eported by Haissaguerre et al. (16), who found J-point
nd/or ST-segment elevation of that magnitude in 31%
f 216 idiopathic VF patients and 5% of 412 control
ubjects matched for age, gender, race, and level of
hysical activity. Also, 22% of our healthy “young ath-
etes” had J-point elevation, a figure consistent with the
7% of young male subjects with J-point elevation
eported by others (4).
eight of J-point elevation. We speculated that in a
anner analogous to the duration of the QT segment,
hich tells apart patients with long QT syndrome and
ealthy individuals, the height of J-point elevation, rather
han its mere presence, would identify patients with VF. We
ould not find a cut-off for J-point elevation that would
eliably distinguish between idiopathic VF patients and
ontrol subjects but recognized a trend toward higher
-point elevation in VF patients. Furthermore, in a recent
arger study, Haissaguerre et al. (16) reported that the J
aves were indeed taller in the idiopathic VF group.
opulation-based studies are needed to define the upper
imit of the “normal J-point elevation.” The location of the
-wave also varied in the different patient groups (Fig. 4).
hy is J-point elevation more common in idiopathic
F? Simultaneous recordings of transmural ECG and in-
racardiac action potentials show that J-point elevation is
he electrocardiographic representation of a voltage gradient
reated during the early phases of repolarization (28). This
oltage gradient results from the different shapes of the
ction potential at different cardiac layers (28). In the
picardium, a higher density of transient outward potassium
J-point elevation > 1 mm
Control 
Adults
Young 
Athletes
Idiopathic 
VF
* **
*
Males
Females
the Different Patient Groupsgroup of leads). VF  ventricular fibrillation.n
hic 
ion inurrent (ITo) leads to a prominent notch during phase I of
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October 7, 2008:1231–8 J-Point Elevation in Idiopathic VFhe action potential that is hardly noticeable in the endo-
ardium (28). This normal difference in ITo current density in
ifferent myocardial areas plays a role in arrhythmogenesis.
he Brugada syndrome represents one extreme of the
pectrum. Here, a reduction in sodium inflow current
aused by mutant sodium channels causes complete loss of
he dome (phase II) of the action potential in the right
entricular epicardium where ITo current density is highest.
onsequently, in the Brugada syndrome there is marked
-point and ST-segment elevation in the right precordial
eads (V1 to V3) and a large dispersion of repolarization that
llows phase-II reentry polymorphic ventricular arrhythmias
o occur even in the absence of triggering extra-systoles (29).
n the other side of the spectrum, vagal-mediated brady-
ardia might increase ITo current in the lateral left ventricle,
eading to J-point and ST-segment elevation in V4 to V6
early repolarization pattern) that is essentially not arrhyth-
ogenic even in the presence of ventricular extra-systoles
25,30,31). One could speculate that J-point elevation in the
nferior leads represents a moderately arrhythmogenic sub-
trate that facilitates polymorphic ventricular arrhythmias
ut only in response to critically timed extra-systoles. This
easoning accommodates 2 observations: 1) J-point eleva-
ion in the inferior leads is more common in patients with
diopathic VF but is also fairly common in healthy control
ubjects; and 2) arrhythmias in idiopathic VF are triggered
y extra-systoles that typically have a superior axis
6,14,32,33), suggesting an inferior origin. These extra-
ystoles, which have been mapped to the Purkinje-fibers
etwork (32,33), have a very short coupling interval (19),
uggesting that an abnormally short refractory period exists
n the surrounding areas.
tudy limitations. We might have underestimated the
requency of J waves for 2 reasons: 1) J-point elevation
ight not be present at all times in a given patient and
ight occur just before VF onset (8,14,16,34), and
) Brugada syndrome is especially common in South East
sia (2,3). Similarly, most case reports describing J-point
levation in idiopathic VF are from the Far East (6–8,13–
5,34). It is possible that J-point elevation is a genetic
haracteristic that was under-represented in our series. In
ontrast, we might have overestimated the frequency of
-point elevation by counting intraventricular conduction
elay as “J-point elevation.” Interventions like heart-rate
lowing (8,34), drug infusions (6,8,15,34,35) or signal-
veraged electrocardiography (16) might be necessary to
eliably distinguish intraventricular conduction block from
-point elevation. Of note, systematic evaluation of idio-
athic VF patients with signal-averaged electrocardiography
performed in the Haissaguerre et al. [16] study) showed
hat only a minority of patients with J-point elevation had
late potentials.” This suggests that J-point elevation repre-
ents “early repolarization” rather than “delayed depolariza-
ion” abnormalities.
linical implications. J-point elevation occurred more fre-
uently among our patients with idiopathic VF than amongimilar control subjects. However, to attach a practical
eaning to this finding, one must take into account that
diopathic VF is rare. That is best achieved by using the
ayes’ law of conditional probabilities. Accordingly, finding
J-wave in a young adult would increase the probability of
diopathic VF from 3.4:100,000 to 11:100,000, a negligible
ifference. Thus, the incidental finding of a J-wave during
creening should not be interpreted as a marker of “in-
reased risk” because the odds for this fatal disease would
till be roughly 1:10,000.
Similar arguments apply to patients with syncope, be-
ause the majority do not have idiopathic VF. Idiopathic VF
atients generally have inducible VF during electrophysi-
logic studies. Yet, understanding the prognostic implica-
ions of VF induction in a patient without documented
pontaneous arrhythmias is problematic (36). Consequently,
he decision to perform an electrophysiologic study, in a
atient with syncope and apparently normal heart, should be
ased on a highly malignant clinical history and not on the
resence or absence of J-point elevation.
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